HNRNPA1P67

Across TCGA pan-cancer cohorts, HNRNPA1P67 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P67’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where HNRNPA1P67 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HNRNPA1P67 is over-expressed in tumor, although a few such as UCEC and HNSC show the opposite, repressed pattern.

COAD, LUSC, and KIRC are the cancer types where HNRNPA1P67 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P67 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.263	<.001	8	view →
LUSC	Female	All	+0.154	.001	4	view →
KIRC	Male	All	+0.092	<.001	4	view →
LIHC	All	All	+0.035	<.001	4	view →
UCEC	All	IV	−0.285	.045	2	view →
READ	Female	All	+0.188	.033	2	view →
THCA	Male	IV	+0.180	.004	2	view →
LUAD	All	All	+0.091	.020	2	view →
HNSC	Female	II,III,IV	−0.059	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

HNRNPA1P67–COAD

Open the COAD breakdown →